Results 141 to 150 of about 259,609 (290)
Immigrants and healthcare in Bulgaria: the responses by policy and legislation
, 2009 The global scale of international migration flows has pushed migrants` health issues high up the policy agenda as worldwide. Bulgaria as a new EU member-state is increasingly affected by immigration pressure.
Kerekovska, Albena; Medical University of Varna +1 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard +11 more
wiley +1 more source
, 2006 Currently information technology is advancing rapidly in the field of public health. For a stable advancement towards the implementation of information technology in the field of public health, systems for implementation and information protection must ...
김소윤
core
Exploring legislative placebo : a new framework for understanding deliberate ineffective legislation
Published online: 26 May 2025This study explores the intriguing phenomenon of legislative actions deliberately designed to be ineffective. Its aim is to broaden the understanding of this practice by introducing the concept of legislative placebo.
STĘPIEŃ, Mateusz, ZOMERSKI, Wojciech
core +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
The medical approach and the social approach to disability: A descriptive analysis
, 2011 The thesis offers a descriptive analysis of how the “medical approach” to disability and the “social approach” to disability understand and analyse disability as an area of inquiry.
Mauri, Christian John
core
Medical cannabis access programme.
, 2020 On 26th June 2019, the Minister for Health signed legislation to allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years.
core